I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 13 studies | 20% ± 5% | |
| endothelial cell | 12 studies | 22% ± 5% | |
| epithelial cell | 6 studies | 27% ± 9% | |
| adipocyte | 6 studies | 19% ± 5% | |
| fibroblast | 6 studies | 21% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 20% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 20% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 21% ± 3% | |
| myeloid cell | 5 studies | 20% ± 3% | |
| CD8-positive, alpha-beta memory T cell | 5 studies | 18% ± 2% | |
| T cell | 4 studies | 17% ± 3% | |
| glutamatergic neuron | 4 studies | 45% ± 19% | |
| dendritic cell | 4 studies | 28% ± 14% | |
| monocyte | 4 studies | 21% ± 3% | |
| macrophage | 4 studies | 24% ± 4% | |
| astrocyte | 4 studies | 21% ± 4% | |
| mast cell | 3 studies | 18% ± 3% | |
| classical monocyte | 3 studies | 22% ± 4% | |
| leukocyte | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| conventional dendritic cell | 3 studies | 25% ± 8% | |
| mature NK T cell | 3 studies | 18% ± 1% | |
| basal cell | 3 studies | 24% ± 9% | |
| lymphocyte | 3 studies | 24% ± 3% | |
| innate lymphoid cell | 3 studies | 19% ± 5% | |
| GABAergic neuron | 3 studies | 47% ± 10% | |
| alveolar macrophage | 3 studies | 28% ± 9% | |
| gamma-delta T cell | 3 studies | 29% ± 7% | |
| transit amplifying cell | 3 studies | 36% ± 16% | |
| neuron | 3 studies | 25% ± 7% | |
| interneuron | 3 studies | 36% ± 20% | |
| oligodendrocyte | 3 studies | 21% ± 2% |
